-
1
-
-
84857992283
-
Numéro thématique : surveillance épidé miologique des causes de décs en France
-
Accessed 9 February 2011
-
Aouba A, Péquignot F, Le Toullec A, et al. Numéro thématique : surveillance épidémiologique des causes de décs en France. Les causes médicales de décs en France en 2004 et leur évolution 1980-2004. Accessed 9 February 2011. http://www.invs.sante.fr/beh/.
-
Les Causes Médicales de Décs en France en 2004 et Leur Évolution 1980-2004
-
-
Aouba A, P.1
-
2
-
-
33745683654
-
Guidelines on the management of stable angina pectoris: Executive summary - The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology
-
DOI 10.1093/eurheartj/ehl001
-
K. Fox, M.A. Garcia, and D. Ardissino Guidelines on the management of stable angina pectoris: executive summary. The task force on the management of stable angina pectoris of the European Society of Cardiology Eur Heart J 27 2006 1341 1381 (Pubitemid 43998110)
-
(2006)
European Heart Journal
, vol.27
, Issue.11
, pp. 1341-1381
-
-
Fox, K.1
Alonso Garcia, M.A.2
Ardissino, D.3
Buszman, P.4
Camici, P.G.5
Crea, F.6
Daly, C.7
De Backer, G.8
Hjemdahl, P.9
Lopez-Sendon, J.10
Marco, J.11
Morais, J.12
Pepper, J.13
Sechtem, U.14
Simoons, M.15
Thygesen, K.16
-
3
-
-
37349031812
-
2007 Chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: A report of the American college of cardiology/American heart association task force on practice guidelines writing group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina
-
DOI 10.1161/CIRCULATIONAHA.107.187930
-
T.D. Fraker Jr., S.D. Fihn, and R.J. Gibbons 2007 chronic angina focused update of the ACC/AHA 2002. Guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002. Guidelines for the management of patients with chronic stable angina Circulation 116 2007 2762 2772 (Pubitemid 350291248)
-
(2007)
Circulation
, vol.116
, Issue.23
, pp. 2762-2772
-
-
Fraker Jr., T.D.1
Fihn, S.D.2
-
4
-
-
73349087536
-
Heart rate distribution and predictors of increased heart rate among French hypertensive patients with stable coronary artery disease. Data from the LHYCORNE cohort
-
L. Lorgis, M. Zeller, and P. Jourdain Heart rate distribution and predictors of increased heart rate among French hypertensive patients with stable coronary artery disease. Data from the LHYCORNE cohort Arch Cardiovasc Dis 102 2009 541 547
-
(2009)
Arch Cardiovasc Dis
, vol.102
, pp. 541-547
-
-
Lorgis, L.1
Zeller, M.2
Jourdain, P.3
-
5
-
-
77956663713
-
Distribution of left ventricular ejection fraction and heart rate values in a cohort of stable coronary patients: The INDYCE registry
-
J.Y. Tabet, M.C. Malergue, and M. Guenoun Distribution of left ventricular ejection fraction and heart rate values in a cohort of stable coronary patients: the INDYCE registry Arch Cardiovasc Dis 103 2010 354 362
-
(2010)
Arch Cardiovasc Dis
, vol.103
, pp. 354-362
-
-
Tabet, J.Y.1
Malergue, M.C.2
Guenoun, M.3
-
6
-
-
72949087977
-
Chronic coronary artery disease: Diagnosis and management
-
A. Cassar, D.R. Holmes Jr., and C.S. Rihal Chronic coronary artery disease: diagnosis and management Mayo Clin Proc 84 2009 1130 1146
-
(2009)
Mayo Clin Proc
, vol.84
, pp. 1130-1146
-
-
Cassar, A.1
Holmes, Jr.D.R.2
Rihal, C.S.3
-
7
-
-
54449097883
-
The evolving role of medical therapy for chronic stable angina
-
F. Eid, and W.E. Boden The evolving role of medical therapy for chronic stable angina Curr Cardiol Rep 10 2008 263 271
-
(2008)
Curr Cardiol Rep
, vol.10
, pp. 263-271
-
-
Eid, F.1
Boden, W.E.2
-
8
-
-
79551693950
-
Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization
-
R. Kones Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization Vasc Health Risk Manag 6 2010 749 774
-
(2010)
Vasc Health Risk Manag
, vol.6
, pp. 749-774
-
-
Kones, R.1
-
11
-
-
77349083281
-
Management of stable coronary artery disease
-
M.E. Pfisterer, M.J. Zellweger, and B.J. Gersh Management of stable coronary artery disease Lancet 375 2010 763 772
-
(2010)
Lancet
, vol.375
, pp. 763-772
-
-
Pfisterer, M.E.1
Zellweger, M.J.2
Gersh, B.J.3
-
12
-
-
77958128969
-
Guidelines on myocardial revascularization: The task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)
-
W. Wijns, P. Kolh, and N. Danchin Guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Eur Heart J 31 2010 2501 2555
-
(2010)
Eur Heart J
, vol.31
, pp. 2501-2555
-
-
Wijns, W.1
Kolh, P.2
Danchin, N.3
-
13
-
-
77949562278
-
Intensive multifactorial intervention for stable coronary artery disease: Optimal medical therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial
-
D.J. Maron, W.E. Boden, and R.A. O'Rourke Intensive multifactorial intervention for stable coronary artery disease: optimal medical therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial J Am Coll Cardiol 55 2010 1348 1358
-
(2010)
J Am Coll Cardiol
, vol.55
, pp. 1348-1358
-
-
Maron, D.J.1
Boden, W.E.2
O'Rourke, R.A.3
-
14
-
-
34247113737
-
Optimal medical therapy with or without PCI for stable coronary disease
-
DOI 10.1056/NEJMoa070829
-
W.E. Boden, R.A. O'Rourke, and K.K. Teo Optimal medical therapy with or without PCI for stable coronary disease N Engl J Med 356 2007 1503 1516 (Pubitemid 46588415)
-
(2007)
New England Journal of Medicine
, vol.356
, Issue.15
, pp. 1503-1516
-
-
Boden, W.E.1
O'Rourke, R.A.2
Teo, K.K.3
Hartigan, P.M.4
Maron, D.J.5
Kostuk, W.J.6
Knudtson, M.7
Dada, M.8
Casperson, P.9
Harris, C.L.10
Chaitman, B.R.11
Shaw, L.12
Gosselin, G.13
Nawaz, S.14
Title, L.M.15
Gau, G.16
Blaustein, A.S.17
Booth, D.C.18
Bates, E.R.19
Spertus, J.A.20
Berman, D.S.21
Mancini, G.B.J.22
Weintraub, W.S.23
more..
-
15
-
-
0033540013
-
Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease
-
[author reply 54-55]
-
D.J. Cohen, J.P. Carrozza, and D.S. Baim Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease N Engl J Med 341 1999 1853 1854 [author reply 54-55]
-
(1999)
N Engl J Med
, vol.341
, pp. 1853-1854
-
-
Cohen, D.J.1
Carrozza, J.P.2
Baim, D.S.3
-
16
-
-
77957281711
-
Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): A randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease
-
W. Hueb, N. Lopes, and B.J. Gersh Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease Circulation 122 2010 949 957
-
(2010)
Circulation
, vol.122
, pp. 949-957
-
-
Hueb, W.1
Lopes, N.2
Gersh, B.J.3
-
17
-
-
67149142042
-
A randomized trial of therapies for type 2 diabetes and coronary artery disease
-
R.L. Frye, P. August, and M.M. Brooks A randomized trial of therapies for type 2 diabetes and coronary artery disease N Engl J Med 360 2009 2503 2515
-
(2009)
N Engl J Med
, vol.360
, pp. 2503-2515
-
-
Frye, R.L.1
August, P.2
Brooks, M.M.3
-
18
-
-
77749264545
-
Controversies in cardiovascular medicine: Chronic stable coronary artery disease: Drugs vs. revascularization
-
M.L. Simoons, and S. Windecker Controversies in cardiovascular medicine: chronic stable coronary artery disease: drugs vs. revascularization Eur Heart J 31 2010 530 541
-
(2010)
Eur Heart J
, vol.31
, pp. 530-541
-
-
Simoons, M.L.1
Windecker, S.2
-
19
-
-
77952575906
-
Aspirin in the secondary prevention of cardiovascular disease: An update of the APTC meta-analysis
-
M. Lievre, and M. Cucherat Aspirin in the secondary prevention of cardiovascular disease: an update of the APTC meta-analysis Fundam Clin Pharmacol 24 2010 385 391
-
(2010)
Fundam Clin Pharmacol
, vol.24
, pp. 385-391
-
-
Lievre, M.1
Cucherat, M.2
-
20
-
-
79851495676
-
Twenty four-hour time-dependent aspirin efficacy in patients with stable coronary artery disease
-
P. Henry, A. Vermillet, and B. Boval Twenty four-hour time-dependent aspirin efficacy in patients with stable coronary artery disease Thromb Haemost 105 2011 336 344
-
(2011)
Thromb Haemost
, vol.105
, pp. 336-344
-
-
Henry, P.1
Vermillet, A.2
Boval, B.3
-
21
-
-
77950796980
-
Aspirin and clopidogrel resistance: Methodological challenges and opportunities
-
A.Y. Gasparyan Aspirin and clopidogrel resistance: methodological challenges and opportunities Vasc Health Risk Manag 6 2010 109 112
-
(2010)
Vasc Health Risk Manag
, vol.6
, pp. 109-112
-
-
Gasparyan, A.Y.1
-
22
-
-
78449281377
-
Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170,000 participants in 26 randomized trials
-
C. Baigent, L. Blackwell, and J. Emberson Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomized trials Lancet 376 2010 1670 1681
-
(2010)
Lancet
, vol.376
, pp. 1670-1681
-
-
Baigent, C.1
Blackwell, L.2
Emberson, J.3
-
23
-
-
78149318321
-
Potent anti-ischaemic effects of statins in chronic stable angina: Incremental benefit beyond lipid lowering?
-
J.E. Deanfield, P. Sellier, and E. Thaulow Potent anti-ischaemic effects of statins in chronic stable angina: incremental benefit beyond lipid lowering? Eur Heart J 31 2010 2650 2659
-
(2010)
Eur Heart J
, vol.31
, pp. 2650-2659
-
-
Deanfield, J.E.1
Sellier, P.2
Thaulow, E.3
-
24
-
-
0034688194
-
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators
-
S. Yusuf, P. Sleight, and J. Pogue Effects of an angiotensin-converting- enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators N Engl J Med 342 2000 145 153
-
(2000)
N Engl J Med
, vol.342
, pp. 145-153
-
-
Yusuf, S.1
Sleight, P.2
Pogue, J.3
-
25
-
-
0042330455
-
Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: Randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)
-
DOI 10.1016/S0140-6736(03)14286-9
-
K.M. Fox Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomized, double-blind, placebo-controlled, multicentre trial (the EUROPA study) Lancet 362 2003 782 788 (Pubitemid 37093919)
-
(2003)
Lancet
, vol.362
, Issue.9386
, pp. 782-788
-
-
Fox, K.M.1
-
26
-
-
0000093848
-
β blockade after myocardial infarction: Systematic review and meta regression analysis
-
N. Freemantle, J. Cleland, and P. Young Beta blockade after myocardial infarction: systematic review and meta regression analysis BMJ 318 1999 1730 1737 (Pubitemid 29290470)
-
(1999)
British Medical Journal
, vol.318
, Issue.7200
, pp. 1730-1737
-
-
Freemantle, N.1
Cleland, J.2
Young, P.3
Mason, J.4
Harrison, J.5
-
27
-
-
33746192571
-
Antianginal Efficacy of Ranolazine When Added to Treatment With Amlodipine. The ERICA (Efficacy of Ranolazine in Chronic Angina) Trial
-
DOI 10.1016/j.jacc.2006.05.044, PII S0735109706015324
-
P.H. Stone, N.A. Gratsiansky, and A. Blokhin Antianginal efficacy of ranolazine when added to treatment with amlodipine: the Efficacy of Ranolazine in Chronic Angina (ERICA) trial J Am Coll Cardiol 48 2006 566 575 (Pubitemid 44093970)
-
(2006)
Journal of the American College of Cardiology
, vol.48
, Issue.3
, pp. 566-575
-
-
Stone, P.H.1
Gratsiansky, N.A.2
Blokhin, A.3
Huang, I.-Z.4
Meng, L.5
-
28
-
-
4544304433
-
Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): Randomized controlled trial
-
P.A. Poole-Wilson, J. Lubsen, and B.A. Kirwan Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomized controlled trial Lancet 364 2004 849 857
-
(2004)
Lancet
, vol.364
, pp. 849-857
-
-
Poole-Wilson, P.A.1
Lubsen, J.2
Kirwan, B.A.3
-
29
-
-
0037070736
-
Effect of nicorandil on coronary events in patients with stable angina: The Impact of Nicorandil in Angina (IONA) randomized trial
-
Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomized trial. Lancet 2002; 359:1269-75.
-
(2002)
Lancet
, vol.359
, pp. 1269-1275
-
-
-
30
-
-
0031979549
-
Traitement betabloquant dans l'infarctus du myocarde aigu
-
N. Danchin, M. Angioi, and J.P. Preiss Beta-blocker therapy in acute myocardial infarction Arch Mal Coeur Vaiss 91 Spec No. 2 1998 43 47 (Pubitemid 28208070)
-
(1998)
Archives des Maladies du Coeur et des Vaisseaux
, vol.91
, Issue.SPEC. ISS. 2
, pp. 43-47
-
-
Danchin, N.1
Angioi, M.2
Preiss, J.-P.3
Jacquemin, L.4
Houriez, P.5
-
31
-
-
0032545984
-
Nitrate therapy for stable angina pectoris
-
DOI 10.1056/NEJM199802193380807
-
J.D. Parker, and J.O. Parker Nitrate therapy for stable angina pectoris N Engl J Med 338 1998 520 531 (Pubitemid 28103137)
-
(1998)
New England Journal of Medicine
, vol.338
, Issue.8
, pp. 520-531
-
-
Parker, J.D.1
Parker, J.O.2
-
32
-
-
0038621643
-
The effect of nitroglycerin on myocardial blood flow in various segments characterized by rest-redistribution thallium SPECT
-
E. Tadamura, M. Mamede, and S. Kubo The effect of nitroglycerin on myocardial blood flow in various segments characterized by rest-redistribution thallium SPECT J Nucl Med 44 2003 745 751 (Pubitemid 39655209)
-
(2003)
Journal of Nuclear Medicine
, vol.44
, Issue.5
, pp. 745-751
-
-
Tadamura, E.1
Mamede, M.2
Kubo, S.3
Toyoda, H.4
Yamamuro, M.5
Iida, H.6
Tamaki, N.7
Nishimura, K.8
Komeda, M.9
Konishi, J.10
-
33
-
-
0020622567
-
Nitroglycerin and long-acting nitrates in clinical practice
-
J. Abrams Nitroglycerin and long-acting nitrates in clinical practice Am J Med 74 1983 85 94 (Pubitemid 13064824)
-
(1983)
American Journal of Medicine
, vol.74
, Issue.6 B
, pp. 85-94
-
-
Abrams, J.1
-
34
-
-
0030937905
-
Nitrate tolerance, rebound, and their clinical relevance in stable angina pectoris, unstable angina, and heart failure
-
DOI 10.1007/BF00053031
-
U. Thadani Nitrate tolerance, rebound, and their clinical relevance in stable angina pectoris, unstable angina and heart failure Cardiovasc Drugs Ther 10 1997 735 742 (Pubitemid 27129777)
-
(1997)
Cardiovascular Drugs and Therapy
, vol.10
, Issue.6
, pp. 735-742
-
-
Thadani, U.1
-
35
-
-
29544447417
-
Cardiac safety in clinical trials of phosphodiesterase 5 inhibitors
-
C.C. Carson 3rd Cardiac safety in clinical trials of phosphodiesterase 5 inhibitors Am J Cardiol 96 2005 37M 41M
-
(2005)
Am J Cardiol
, vol.96
-
-
Carson III, C.C.1
-
36
-
-
0034770272
-
Potassium channel openers in myocardial ischaemia: Therapeutic potential of nicorandil
-
A.H. Gomma, H.J. Purcell, and K.M. Fox Potassium channel openers in myocardial ischaemia: therapeutic potential of nicorandil Drugs 61 2001 1705 1710 (Pubitemid 32980502)
-
(2001)
Drugs
, vol.61
, Issue.12
, pp. 1705-1710
-
-
Gomma, A.H.1
Purcell, H.J.2
Fox, K.M.3
-
37
-
-
0033756612
-
Nicorandil. An updated review of its use in ischaemic heart disease with emphasis on its cardioprotective effects
-
A. Markham, G.L. Plosker, and K.L. Goa Nicorandil. An updated review of its use in ischaemic heart disease with emphasis on its cardioprotective effects Drugs 60 2000 955 974
-
(2000)
Drugs
, vol.60
, pp. 955-974
-
-
Markham, A.1
Plosker, G.L.2
Goa, K.L.3
-
38
-
-
0037396373
-
Metabolic therapy in the treatment of ischaemic heart disease: The pharmacology of trimetazidine
-
DOI 10.1046/j.1472-8206.2003.00154.x
-
W.C. Stanley, and M. Marzilli Metabolic therapy in the treatment of ischaemic heart disease: the pharmacology of trimetazidine Fundam Clin Pharmacol 17 2003 133 145 (Pubitemid 36513204)
-
(2003)
Fundamental and Clinical Pharmacology
, vol.17
, Issue.2
, pp. 133-145
-
-
Stanley, W.C.1
Marzilli, M.2
-
40
-
-
84857996385
-
-
Commission nationale de pharmacovigilance Accessed 4 July 2011
-
Commission nationale de pharmacovigilance. Compte rendu de la réunion du mardi 19 mai 2009. Accessed 4 July 2011. http://www.afssaps. fr/var/afssaps-site/storage/original/application/ 61c6847bb097168d0bfe266d5515ec7b.pdf.
-
Compte Rendu de la Réunion du Mardi 19 Mai 2009
-
-
-
41
-
-
84858002009
-
-
Accessed 4 July 2011
-
Réunion de la Commission d'AMM du 7 avril 2011. Accessed 4 July 2011. http://www.afssaps.fr/Activites/Expertise/Commissions-et-groupes-de- travail/Commission-d-autorisation-de-mise-sur-le-marche/Reunion-de-la- commission-d-AMM-du-07-avril-2011/(language)/fre-FR.
-
Réunion de la Commission d'Amm du 7 Avril 2011
-
-
-
42
-
-
0037448788
-
Antianginal and anti-ischemic effects of ivabradine, an I(f) inhibitor, in stable angina: A randomized, double-blind, multicentered, placebo-controlled trial
-
J.S. Borer, K. Fox, and P. Jaillon Antianginal and anti-ischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial Circulation 107 2003 817 823
-
(2003)
Circulation
, vol.107
, pp. 817-823
-
-
Borer, J.S.1
Fox, K.2
Jaillon, P.3
-
43
-
-
27944492366
-
f inhibitor, compared with atenolol in patients with chronic stable angina
-
DOI 10.1093/eurheartj/ehi586
-
J.C. Tardif, I. Ford, and M. Tendera Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina Eur Heart J 26 2005 2529 2536 (Pubitemid 41677303)
-
(2005)
European Heart Journal
, vol.26
, Issue.23
, pp. 2529-2536
-
-
Tardif, J.-C.1
Ford, I.2
Tendera, M.3
Bourassa, M.G.4
Fox, K.5
-
44
-
-
63349103473
-
Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: A 4-month, randomized, placebo-controlled trial
-
J.C. Tardif, P. Ponikowski, and T. Kahan Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial Eur Heart J 30 2009 540 548
-
(2009)
Eur Heart J
, vol.30
, pp. 540-548
-
-
Tardif, J.C.1
Ponikowski, P.2
Kahan, T.3
-
45
-
-
50649109186
-
Ivabradine for patients with stable coronary artery disease and left ventricular systolic dysfunction (BEAUTIFUL): A randomized, double-blind, placebo-controlled trial
-
K. Fox, I. Ford, and P.G. Steg Ivabradine for patients with stable coronary artery disease and left ventricular systolic dysfunction (BEAUTIFUL): a randomized, double-blind, placebo-controlled trial Lancet 372 2008 807 816
-
(2008)
Lancet
, vol.372
, pp. 807-816
-
-
Fox, K.1
Ford, I.2
Steg, P.G.3
-
46
-
-
77957359383
-
I(f) inhibition in cardiovascular diseases
-
C. Thollon, and J.P. Vilaine I(f) inhibition in cardiovascular diseases Adv Pharmacol 59 2010 53 92
-
(2010)
Adv Pharmacol
, vol.59
, pp. 53-92
-
-
Thollon, C.1
Vilaine, J.P.2
-
47
-
-
64049101368
-
Selective Hcn1 channels inhibition by ivabradine in mouse rod photoreceptors
-
G.C. Demontis, C. Gargini, and T.G. Paoli Selective Hcn1 channels inhibition by ivabradine in mouse rod photoreceptors Invest Ophthalmol Vis Sci 50 2009 1948 1955
-
(2009)
Invest Ophthalmol Vis Sci
, vol.50
, pp. 1948-1955
-
-
Demontis, G.C.1
Gargini, C.2
Paoli, T.G.3
-
48
-
-
36849034850
-
Ranolazine: A new option in the management of chronic stable angina
-
DOI 10.1592/phco.27.12.1659
-
P.P. Dobesh, and T.C. Trujillo Ranolazine: a new option in the management of chronic stable angina Pharmacotherapy 27 2007 1659 1676 (Pubitemid 350234315)
-
(2007)
Pharmacotherapy
, vol.27
, Issue.12
, pp. 1659-1676
-
-
Dobesh, P.P.1
Trujillo, T.C.2
-
49
-
-
53349097796
-
Ranolazine for chronic stable angina
-
D.T. Nash, and S.D. Nash Ranolazine for chronic stable angina Lancet 372 2008 1335 1341
-
(2008)
Lancet
, vol.372
, pp. 1335-1341
-
-
Nash, D.T.1
Nash, S.D.2
-
50
-
-
79955418005
-
Emerging clinical role of ranolazine in the management of angina
-
D.S. Vadnais, and N.K. Wenger Emerging clinical role of ranolazine in the management of angina Ther Clin Risk Manag 6 2010 517 530
-
(2010)
Ther Clin Risk Manag
, vol.6
, pp. 517-530
-
-
Vadnais, D.S.1
Wenger, N.K.2
-
51
-
-
0348129532
-
Effects of Ranolazine with Atenolol, Amlodipine, or Diltiazem on Exercise Tolerance and Angina Frequency in Patients with Severe Chronic Angina: A Randomized Controlled Trial
-
DOI 10.1001/jama.291.3.309
-
B.R. Chaitman, C.J. Pepine, and J.O. Parker Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial JAMA 291 2004 309 316 (Pubitemid 38101603)
-
(2004)
Journal of the American Medical Association
, vol.291
, Issue.3
, pp. 309-316
-
-
Chaitman, B.R.1
Pepine, C.J.2
Parker, J.O.3
Skopal, J.4
Chumakova, G.5
Kuch, J.6
Wang, W.7
Skettino, S.L.8
Wolff, A.A.9
-
52
-
-
11144356285
-
Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina
-
DOI 10.1016/j.jacc.2003.11.045, PII S0735109704001925
-
B.R. Chaitman, S.L. Skettino, and J.O. Parker Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina J Am Coll Cardiol 43 2004 1375 1382 (Pubitemid 38496341)
-
(2004)
Journal of the American College of Cardiology
, vol.43
, Issue.8
, pp. 1375-1382
-
-
Chaitman, B.R.1
Skettino, S.L.2
Parker, J.O.3
Hanley, P.4
Meluzin, J.5
Kuch, J.6
Pepine, C.J.7
Wang, W.8
Nelson, J.J.9
Hebert, D.A.10
Wolff, A.A.11
-
53
-
-
64649089888
-
Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes (MERLIN-TIMI) 36 Trial
-
S.R. Wilson, B.M. Scirica, and E. Braunwald Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes (MERLIN-TIMI) 36 Trial J Am Coll Cardiol 53 2009 1510 1516
-
(2009)
J Am Coll Cardiol
, vol.53
, pp. 1510-1516
-
-
Wilson, S.R.1
Scirica, B.M.2
Braunwald, E.3
-
54
-
-
69749115980
-
-
Commisssion de transparence du 4 novembre 2009. Accessed 4 July 2011
-
Haute Autorité de santé. Commisssion de transparence du 4 novembre 2009. Accessed 4 July 2011. http://www.has-sante.fr/portail/upload/ docs/application/pdf/2009-11/ranexa ct-6981.pdf.
-
Haute Autorité de Santé
-
-
-
55
-
-
0034953509
-
Are patients suffering from stable angina receiving optimal medical treatment?
-
M.D. Beaulieu, R. Blais, and A. Jacques Are patients suffering from stable angina receiving optimal medical treatment? QJM 94 2001 301 308 (Pubitemid 32600489)
-
(2001)
QJM - Monthly Journal of the Association of Physicians
, vol.94
, Issue.6
, pp. 301-308
-
-
Beaulieu, M.-D.1
Blais, R.2
Jacques, A.3
Battista, R.N.4
Lebeau, R.5
Brophy, J.6
-
56
-
-
4143086047
-
Suboptimal pharmacotherapeutic management of chronic stable angina in the primary care setting
-
DOI 10.1016/j.amjmed.2004.02.044, PII S0002934304002748
-
F.C. Wiest, C.L. Bryson, and M. Burman Suboptimal pharmacotherapeutic management of chronic stable angina in the primary care setting Am J Med 117 2004 234 241 (Pubitemid 39092716)
-
(2004)
American Journal of Medicine
, vol.117
, Issue.4
, pp. 234-241
-
-
Wiest, F.C.1
Bryson, C.L.2
Burman, M.3
McDonell, M.B.4
Henikoff, J.G.5
Fihn, S.D.6
-
57
-
-
33745683661
-
The impact of guideline compliant medical therapy on clinical outcome in patients with stable angina: Findings from the Euro Heart Survey of stable angina
-
DOI 10.1093/eurheartj/ehl005
-
C. Daly, F. Clemens, and J.L. Lopez-Sendon The impact of guideline compliant medical therapy on clinical outcome in patients with stable angina: findings from the Euro Heart Survey of stable angina Eur Heart J 27 2006 1298 1304 (Pubitemid 43998102)
-
(2006)
European Heart Journal
, vol.27
, Issue.11
, pp. 1298-1304
-
-
Daly, C.1
Clemens, F.2
Lopez-Sendon, J.L.3
Tavazzi, L.4
Boersma, E.5
Danchin, N.6
Delahaye, F.7
Gitt, A.8
Julian, D.9
Mulcahy, D.10
Ruzyllo, W.11
Thygesen, K.12
Verheugt, F.13
Fox, K.M.14
-
58
-
-
77953063545
-
Is there a Failure to Optimize theRapy in anGina pEcToris (FORGET) study?
-
D.H. Elder, M. Pauriah, and C.C. Lang Is there a Failure to Optimize theRapy in anGina pEcToris (FORGET) study? QJM 103 2010 305 310
-
(2010)
QJM
, vol.103
, pp. 305-310
-
-
Elder, D.H.1
Pauriah, M.2
Lang, C.C.3
-
59
-
-
50649089781
-
Heart rate as a prognostic risk factor in patients with coronary artery disease and left ventricular systolic dysfunction (BEAUTIFUL): A subgroup analysis of a randomized controlled trial
-
K. Fox, I. Ford, and P.G. Steg Heart rate as a prognostic risk factor in patients with coronary artery disease and left ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomized controlled trial Lancet 372 2008 817 821
-
(2008)
Lancet
, vol.372
, pp. 817-821
-
-
Fox, K.1
Ford, I.2
Steg, P.G.3
-
60
-
-
78650170501
-
What is the optimal blood pressure in patients after acute coronary syndromes?: Relationship of blood pressure and cardiovascular events in the PRavastatin or atorVastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction (PROVE IT-TIMI) 22 trial
-
S. Bangalore, J. Qin, and S. Sloan What is the optimal blood pressure in patients after acute coronary syndromes?: Relationship of blood pressure and cardiovascular events in the PRavastatin OR atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction (PROVE IT-TIMI) 22 trial Circulation 122 2010 2142 2151
-
(2010)
Circulation
, vol.122
, pp. 2142-2151
-
-
Bangalore, S.1
Qin, J.2
Sloan, S.3
-
61
-
-
77955462469
-
Coronary revascularization strategy and outcomes according to blood pressure (from the International Verapamil SR-Trandolapril Study [INVEST])
-
S.J. Denardo, F.H. Messerli, and E. Gaxiola Coronary revascularization strategy and outcomes according to blood pressure (from the International Verapamil SR-Trandolapril Study [INVEST]) Am J Cardiol 106 2010 498 503
-
(2010)
Am J Cardiol
, vol.106
, pp. 498-503
-
-
Denardo, S.J.1
Messerli, F.H.2
Gaxiola, E.3
-
62
-
-
84857996173
-
Guide Affection de Longue Durée
-
Haute Autorité de Santé Accessed 9 February 2010
-
Haute Autorité de santé. Guide affection de longue durée. Maladie coronarienne. Accessed 9 February 2010. http://www.has-sante.fr/portail/jcms/c-534304/ald-n13-maladie-coronarienne.
-
Maladie coronarienne
-
-
|